MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-30-2025
AtriCure Operating Cash Flow 2011-2025 | ATRC
Annual Operating Cash Flow AtriCure
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12.2 M | 4.48 M | -22.1 M | -13.8 M | -19.9 M | -15.8 M | -4.17 M | -8.94 M | -15.1 M | -7.84 M | - | -5.22 M | -1.94 M | -1.99 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 12.2 M | -22.1 M | -7.7 M |
Quarterly Operating Cash Flow AtriCure
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | -11 M | - | - | - | -21 M | - | - | - | -4.08 M | - | -22.2 M | - | -24.6 M | - | -14.1 M | - | -9.32 M | - | -23.8 M | -27.6 M | -16.1 M | - | -12.3 M | -9.69 M | -13.4 M | - | -5.16 M | -10.4 M | -9.43 M | - | -10.5 M | -10.6 M | -9.55 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -2.57 M | - | -1.74 M | -1.28 M | -1.08 M | - | -859 K | -504 K | -872 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -504 K | -27.6 M | -10.5 M |
Operating Cash Flow of other stocks in the Medical instruments industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Baxter International
BAX
|
1.02 B | $ 19.32 | 1.05 % | $ 9.85 B |  USA |
 |
Becton, Dickinson and Company
BDX
|
3.33 B | $ 196.18 | -0.01 % | $ 56.4 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
-9.85 M | $ 5.47 | -0.01 % | $ 110 M | USA |
 |
Harvard Bioscience
HBIO
|
14 M | $ 0.71 | -1.78 % | $ 30.1 M | USA |
 |
Alcon
ALC
|
1.34 B | $ 80.33 | 0.26 % | $ 40.4 B |  Schweiz |
 |
Repro Med Systems
KRMD
|
-4.89 M | $ 6.25 | -3.55 % | $ 285 M | USA |
 |
iRhythm Technologies
IRTC
|
3.39 M | $ 177.0 | 0.68 % | $ 5.52 B | USA |
 |
ICU Medical
ICUI
|
204 M | $ 148.17 | 0.81 % | $ 3.61 B | USA |
 |
LeMaitre Vascular
LMAT
|
44.1 M | $ 83.95 | -0.46 % | $ 1.88 B | USA |
 |
Atrion Corporation
ATRI
|
20 K | - | - | $ 810 M | USA |
 |
electroCore
ECOR
|
-14.7 M | $ 4.93 | 1.54 % | $ 27.2 K | USA |
 |
Isoray
ISR
|
-18.3 M | - | 0.03 % | $ 108 M | USA |
 |
AngioDynamics
ANGO
|
-10.1 M | $ 13.12 | -0.3 % | $ 536 M | USA |
 |
Merit Medical Systems
MMSI
|
221 M | $ 87.36 | -0.03 % | $ 5.09 B | USA |
 |
The Cooper Companies
COO
|
796 M | $ 82.55 | -0.03 % | $ 16.4 B | USA |
 |
Glaukos Corporation
GKOS
|
-57.8 M | $ 116.08 | -0.56 % | $ 5.62 B | USA |
 |
Haemonetics Corporation
HAE
|
182 M | $ 80.39 | 0.36 % | $ 4.05 B | USA |
 |
InfuSystem Holdings
INFU
|
17.5 M | $ 8.93 | -1.71 % | $ 184 M | USA |
 |
Masimo Corporation
MASI
|
196 M | $ 132.7 | -0.44 % | $ 7.07 B | USA |
 |
OraSure Technologies
OSUR
|
27.4 M | $ 2.43 | - | $ 181 M | USA |
 |
Intuitive Surgical
ISRG
|
2.42 B | $ 578.08 | 0.16 % | $ 205 B | USA |
 |
Microbot Medical
MBOT
|
-8.53 M | $ 2.16 | -0.88 % | $ 22 M |  Israel |
 |
Milestone Scientific
MLSS
|
-2.92 M | $ 0.29 | -1.41 % | $ 23.1 M | USA |
 |
Nephros
NEPH
|
827 K | $ 4.98 | -4.78 % | $ 51.7 M | USA |
 |
STERIS plc
STE
|
1.15 B | $ 255.64 | 0.02 % | $ 25.2 B | USA |
 |
NeuroMetrix
NURO
|
-7.13 M | - | 5.05 % | $ 9.02 M | USA |
 |
Envista Holdings Corporation
NVST
|
336 M | $ 21.99 | -0.05 % | $ 3.79 B | USA |
 |
Predictive Oncology
POAI
|
-12.4 M | - | - | $ 32.4 M | USA |
 |
Pro-Dex
PDEX
|
-1.68 M | $ 39.33 | -2.65 % | $ 129 M | USA |
 |
Utah Medical Products
UTMD
|
22.3 M | $ 56.66 | 0.66 % | $ 206 M | USA |
 |
Pulse Biosciences
PLSE
|
-33 M | $ 14.45 | -2.76 % | $ 694 M | USA |
 |
ResMed
RMD
|
351 M | $ 245.14 | 0.3 % | $ 35.8 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
461 M | $ 11.47 | 3.66 % | $ 2.33 B | USA |
 |
Repligen Corporation
RGEN
|
114 M | $ 165.37 | -0.18 % | $ 9.21 M | USA |
 |
BioLife Solutions
BLFS
|
8.43 M | $ 24.95 | -1.81 % | $ 1.15 B | USA |
 |
Stereotaxis
STXS
|
-9.14 M | $ 2.46 | 1.23 % | $ 199 M | USA |
 |
STAAR Surgical Company
STAA
|
15.7 M | $ 23.37 | -1.1 % | $ 1.15 B | USA |
 |
Retractable Technologies
RVP
|
-11.6 M | $ 0.82 | -0.51 % | $ 24.5 M | USA |
 |
West Pharmaceutical Services
WST
|
653 M | $ 274.28 | -0.95 % | $ 20 B | USA |